Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Inorg Biochem ; 170: 160-168, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28249224

RESUMEN

Alzheimer's and Parkinson's diseases share similar amyloidogenic mechanisms, in which metal ions might play an important role. In this last neuropathy, misfolding and aggregation of α-synuclein (α-Syn) are crucial pathological events. A moderate metal-binding compound, namely, 8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone (INHHQ), which was previously reported as a potential 'Metal-Protein Attenuating Compound' for Alzheimer's treatment, is well-tolerated by healthy Wistar rats and does not alter their major organ weights, as well as the tissues' reduced glutathione and biometal levels, at a concentration of 200mgkg-1. INHHQ definitively crosses the blood-brain barrier and can be detected in the brain of rats so late as 24h after intraperitoneal administration. After 48h, brain clearance is complete. INHHQ is able to disrupt, in vitro, anomalous copper-α-Syn interactions, through a mechanism probably involving metal ions sequestering. This compound is non-toxic to H4 (human neuroglioma) cells and partially inhibits intracellular α-Syn oligomerization. INHHQ, thus, shows definite potential as a therapeutic agent against Parkinson's as well.


Asunto(s)
Barrera Hematoencefálica/metabolismo , Quelantes , Hidrazonas , Enfermedad de Parkinson Secundaria/tratamiento farmacológico , Animales , Quelantes/síntesis química , Quelantes/química , Quelantes/farmacocinética , Quelantes/farmacología , Evaluación Preclínica de Medicamentos , Hidrazonas/síntesis química , Hidrazonas/química , Hidrazonas/farmacocinética , Hidrazonas/farmacología , Masculino , Enfermedad de Parkinson Secundaria/metabolismo , Ratas , Ratas Wistar
2.
Environ Pollut ; 213: 785-792, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27038210

RESUMEN

In the present study, the concentration of trace elements, total mercury (Hg) and selenium (Se) and mercury forms (MeHg, Hginorg and HgSe) in the vulnerable coastal dolphins Pontoporia blainvillei and Sotalia guianensis were appraised and compared, using metallothioneins (MT) and glutathione (GSH) as biomarkers for trace element exposure. The trace element concentrations varied between muscle and liver tissues, with liver of all dolphin specimens showing higher Hg and Se concentrations than those found in muscle. Hg, MeHg and Hginorg molar concentrations showed a clear increase with Se molar concentrations in the liver of both dolphins, and Se concentrations were higher than those of Hg on a molar basis. Se plays a relevant role in the detoxification of MeHg in the hepatic tissue of both dolphins, forming Hg-Se amorphous crystals in liver. In contrast, MT were involved in the detoxification process of Hginorg in liver. GSH levels in P. blainvillei and S. guianensis muscle tissue suggest that these dolphins have different diving capacities. Muscle Hg concentrations were associated to this tripeptide, which protects dolphin cells against Hg stress.


Asunto(s)
Buceo/fisiología , Delfines/metabolismo , Glutatión/metabolismo , Mercurio/análisis , Metalotioneína/metabolismo , Selenio/análisis , Contaminantes Químicos del Agua/análisis , Animales , Biomarcadores/metabolismo , Brasil , Femenino , Inactivación Metabólica , Hígado/metabolismo , Masculino , Mercurio/farmacocinética , Compuestos de Mercurio/análisis , Compuestos de Mercurio/farmacocinética , Compuestos de Metilmercurio/análisis , Compuestos de Metilmercurio/farmacocinética , Músculos/metabolismo , Estrés Oxidativo/efectos de los fármacos , Selenio/farmacocinética , Compuestos de Selenio/análisis , Compuestos de Selenio/farmacocinética , Oligoelementos/análisis , Oligoelementos/farmacocinética , Contaminantes Químicos del Agua/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA